These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 8959343)

  • 1. Identification of a set of protein species approximately 40 kDa as high-affinity DNA binding factor(s) to the cell cycle regulatory region of the human thymidine kinase promoter.
    Kim EC; Rawlings SL; Li LJ; Roy B; Lee AS
    Cell Growth Differ; 1996 Dec; 7(12):1741-9. PubMed ID: 8959343
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Analysis of sequence-specific binding activity of cis-elements in human thymidine kinase gene promoter during G1/S phase transition.
    Good L; Chen J; Chen KY
    J Cell Physiol; 1995 Jun; 163(3):636-44. PubMed ID: 7775606
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Isolation and initial characterization of the BRCA2 promoter.
    Davis PL; Miron A; Andersen LM; Iglehart JD; Marks JR
    Oncogene; 1999 Oct; 18(44):6000-12. PubMed ID: 10557089
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Transcriptional control elements of the rat thymidylate synthase promoter: evolutionary conservation of regulatory features.
    Lee Y; Johnson LF
    Exp Cell Res; 2000 Jul; 258(1):53-64. PubMed ID: 10912787
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Transcription factors of the Sp1 family: interaction with E2F and regulation of the murine thymidine kinase promoter.
    Rotheneder H; Geymayer S; Haidweger E
    J Mol Biol; 1999 Nov; 293(5):1005-15. PubMed ID: 10547281
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Distinct recruitment of E2F family members to specific E2F-binding sites mediates activation and repression of the E2F1 promoter.
    Araki K; Nakajima Y; Eto K; Ikeda MA
    Oncogene; 2003 Oct; 22(48):7632-41. PubMed ID: 14576826
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Regulation of the cdk inhibitor p21 gene during cell cycle progression is under the control of the transcription factor E2F.
    Hiyama H; Iavarone A; Reeves SA
    Oncogene; 1998 Mar; 16(12):1513-23. PubMed ID: 9569018
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Transcriptional regulation of the mouse PNRC2 promoter by the nuclear factor Y (NFY) and E2F1.
    Zhou D; Masri S; Ye JJ; Chen S
    Gene; 2005 Nov; 361():89-100. PubMed ID: 16181749
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Temporal regulation of cyclin A-p107 and p33cdk2 complexes binding to a human thymidine kinase promoter element important for G1-S phase transcriptional regulation.
    Li LJ; Naeve GS; Lee AS
    Proc Natl Acad Sci U S A; 1993 Apr; 90(8):3554-8. PubMed ID: 8475104
    [TBL] [Abstract][Full Text] [Related]  

  • 10. NF-Y-mediated trans-activation of the human thymidine kinase promoter is closely linked to activation of cyclin-dependent kinase.
    Chang ZF; Huang DY; Hu SF
    J Cell Biochem; 1999 Nov; 75(2):300-9. PubMed ID: 10502302
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Down-regulation of cyclin A gene expression upon genotoxic stress correlates with reduced binding of free E2F to the promoter.
    Spitkovsky D; Schulze A; Boye B; Jansen-Dürr P
    Cell Growth Differ; 1997 Jun; 8(6):699-710. PubMed ID: 9186003
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A novel factor distinct from E2F mediates C-MYC promoter activation through its E2F element during exit from quiescence.
    Alvaro-Blanco J; Martínez-Gac L; Calonge E; Rodríguez-Martínez M; Molina-Privado I; Redondo JM; Alcamí J; Flemington EK; Campanero MR
    Carcinogenesis; 2009 Mar; 30(3):440-8. PubMed ID: 19126644
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cell cycle-dependent regulation of the Skp2 promoter by GA-binding protein.
    Imaki H; Nakayama K; Delehouzee S; Handa H; Kitagawa M; Kamura T; Nakayama KI
    Cancer Res; 2003 Aug; 63(15):4607-13. PubMed ID: 12907639
    [TBL] [Abstract][Full Text] [Related]  

  • 14. ATF1 and CREB trans-activate a cell cycle regulated histone H4 gene at a distal nuclear matrix associated promoter element.
    Guo B; Stein JL; van Wijnen AJ; Stein GS
    Biochemistry; 1997 Nov; 36(47):14447-55. PubMed ID: 9398163
    [TBL] [Abstract][Full Text] [Related]  

  • 15. E2F and GATA-1 are required for the Sertoli cell-specific promoter activity of the follicle-stimulating hormone receptor gene.
    Kim JS; Griswold MD
    J Androl; 2001; 22(4):629-39. PubMed ID: 11451360
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Association of Pur alpha and E2F-1 suppresses transcriptional activity of E2F-1.
    Darbinian N; Gallia GL; Kundu M; Shcherbik N; Tretiakova A; Giordano A; Khalili K
    Oncogene; 1999 Nov; 18(46):6398-402. PubMed ID: 10597240
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Regulation of E2F transcription by cyclin E-Cdk2 kinase mediated through p300/CBP co-activators.
    Morris L; Allen KE; La Thangue NB
    Nat Cell Biol; 2000 Apr; 2(4):232-9. PubMed ID: 10783242
    [TBL] [Abstract][Full Text] [Related]  

  • 18. E2F-6: a novel member of the E2F family is an inhibitor of E2F-dependent transcription.
    Cartwright P; Müller H; Wagener C; Holm K; Helin K
    Oncogene; 1998 Aug; 17(5):611-23. PubMed ID: 9704927
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Timing of cyclin E gene expression depends on the regulated association of a bipartite repressor element with a novel E2F complex.
    Le Cam L; Polanowska J; Fabbrizio E; Olivier M; Philips A; Ng Eaton E; Classon M; Geng Y; Sardet C
    EMBO J; 1999 Apr; 18(7):1878-90. PubMed ID: 10202151
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The periodic down regulation of Cyclin E gene expression from exit of mitosis to end of G(1) is controlled by a deacetylase- and E2F-associated bipartite repressor element.
    Polanowska J; Fabbrizio E; Le Cam L; Trouche D; Emiliani S; Herrera R; Sardet C
    Oncogene; 2001 Jul; 20(31):4115-27. PubMed ID: 11464278
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.